Form 8-K - Current report:
SEC Accession No. 0000950170-23-073432
Filing Date
2023-12-28
Accepted
2023-12-28 06:40:27
Documents
12
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20231221.htm   iXBRL 8-K 42055
  Complete submission text file 0000950170-23-073432.txt   159825

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20231221_lab.xml EX-101.LAB 13342
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20231221_pre.xml EX-101.PRE 9848
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20231221.xsd EX-101.SCH 2481
6 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20231221_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 231519296
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)